Royce & Associates’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.2M | Sell |
247,401
-49,799
| -17% | -$6.67M | 0.34% | 76 |
|
|
2025
Q1 | $20M | Buy |
297,200
+2
| +0% | +$135 | 0.22% | 137 |
|
|
2024
Q4 | $18.5M | Hold |
297,198
| – | – | 0.17% | 168 |
|
|
2024
Q3 | $46.7M | Sell |
297,198
-4,000
| -1% | -$628K | 0.42% | 51 |
|
|
2024
Q2 | $45.4M | Sell |
301,198
-14,000
| -4% | -$2.11M | 0.42% | 49 |
|
|
2024
Q1 | $23.3M | Sell |
315,198
-36,500
| -10% | -$2.7M | 0.21% | 133 |
|
|
2023
Q4 | $27.8M | Buy |
351,698
+210,000
| +148% | +$16.6M | 0.26% | 108 |
|
|
2023
Q3 | $7.76M | Buy |
141,698
+4,198
| +3% | +$230K | 0.08% | 359 |
|
|
2023
Q2 | $11.5M | Sell |
137,500
-22,000
| -14% | -$1.85M | 0.11% | 271 |
|
|
2023
Q1 | $12.1M | Sell |
159,500
-32,500
| -17% | -$2.46M | 0.12% | 241 |
|
|
2022
Q4 | $11.9M | Buy |
192,000
+40,000
| +26% | +$2.47M | 0.12% | 251 |
|
|
2022
Q3 | $6.34M | Buy |
152,000
+10,000
| +7% | +$417K | 0.07% | 394 |
|
|
2022
Q2 | $4.47M | Buy |
142,000
+55,000
| +63% | +$1.73M | 0.05% | 502 |
|
|
2022
Q1 | $2.34M | Buy |
87,000
+26,000
| +43% | +$701K | 0.02% | 692 |
|
|
2021
Q4 | $1.17M | Buy |
+61,000
| New | +$1.17M | 0.01% | 784 |
|
|
2020
Q4 | – | Sell |
-41,000
| Closed | -$565K | – | 1040 |
|
|
2020
Q3 | $565K | Buy |
+41,000
| New | +$565K | 0.01% | 848 |
|